This study examines the mRNA distribution of these convertases in the rat CNS and compares their expression with the previously characterized processing enzymes carboxypeptidase E (CPE) and peptidylglycine a-amidating monooxygenase (PAM) using in situ hybridization histochemistry.
Furin mRNA was ubiquitously distributed and detected both in neurons and non-neuronal tissue throughout the brain with a higher abundance in ependyma, the circumventricular organs, the islands of Calleja, hippocampus, and allocottex.
The cellular localization of PC1 and PC2 was exclusively neuronal with highest concentrations in known neuropeptide-rich brain regions. In general, PC2 was more widely expressed than PC1 in the CNS, although many regional variations were detected. The participation of neuropeptides in the modulation of a variety of CNS functions is well established. Many neuropeptides are synthesized as inactive precursor proteins, which undergo an enzymatic cascade of posttranslational processing and modification events during their intracellular transport before the final bioactive products are secreted and act at either pre-or postsynaptic receptors. Initial endoproteolytic cleavage occurs C-terminal to pairs of basic amino acids such as lysine-arginine (Docherty and Steiner, 1982) and is followed by the removal of the basic residues by exopeptidases. Further modifications can occur in the form of N-terminal acetylation or C-terminal amidation, which is essential for the bioactivity of many neuropeptides. Recent success in the molecular characterization of these enzymes has provided us with the necessary tools to investigate the regulation of neuropeptide expression at the level of the enzymes involved in proneuropeptide processing. The primary amino acid sequence of two postcleavage modification enzymes, carboxypeptidase E (CPE) (Fricker et al., 1989) and peptidylglycine a-amidating monooxygenase (PAM) (Eipper et al., 1987) have been characterized by cDNA cloning, and their brain distribution (Macumber et al., 1990; Schafer et al., 1992) tissue-specific expression, and regulation have been reported (Bondy et al., 1989; Braas et al., 1989; Grimwood et al., 1989; Ouafik et al., 1989; Thiele et al., 1989; Fricker et al., 1990a,b; Hook et al., 1990) . More recently, the identification of endoproteolytic enzymes has been advanced by the cloning of the yeast enzyme Kexin and the demonstration of its ability to process mammalian protein precursors both in vitro and in vivo (Mizuno et al., 1988; Thomas et al., 1988; Fuller et al., 1989; Zollinger et al., 1990; Foster et al., 199 1) . Finally, the long search for the homologous mammalian proteinases led to the discovery of three distinct proteins belonging to the class of Kexin/subtilisin-like enzymes, namely, furin (Roebroek et al., 1986; Fuller et al., 1989; van den Ouweland, 1990 ) PC 1 (Seidah et al., 1990 (Seidah et al., , 1991 also known as PC3 (Smeekens et al., 1991) and PC2 (Seidah et al., 1990; Smeekens and Steiner, 1990) .
Furin, the product of thefur gene (also known as PACE (Wise et al., 1990) has been shown in cellular cotransfection experiments to cleave efficiently the protein precursors of von Willebrand factor, NGF, complement C3, and proalbumin (Bresnahan et al., 1990; Van de Ven et al., 1990; Wise et al., 1990; Misumi et al., 199 1) . The ubiquitous distribution of furin mRNA, which is present in most tissues and cell lines (Schalken et al., 1987; Bresnahan et al., 1990; Hatsuzawa et al., 1990) suggests that furin has a wider spectrum of action than just the specific processing of proneuropeptides, which are highly concentrated in neuronal and endocrine tissues. The application of PCR-assisted cDNA cloning led to the discovery of two more subtilisin-like enzymes, the prohormone convertases PC1 (Seidah et al., 1990 (Seidah et al., , 1991 Smeekens et al., 1991) and PC2 (Seidah et al., 1990; Smeekens and Steiner, 1990) . In situ hybridization analysis revealed their tissue-specific distribution, and as expected for putative prohormone cleavage enzymes, a high mRNA concentration was found in mouse neuronal and endocrine tissues (Seidah et al., 1990, 199 1) . Cotransfection experiments not only demonstrated their capacity to process correctly the prohormones proopiomelanocortin (POMC) (Benjannet et al., 199 1; Thomas et al., 199 1) and prorenin (Benjannet et al., 1992) , but also showed their distinct cleavage specificities.
For example, in the pituitary anterior lobe, POMC is processed by PC1 into ACTH and /3-lipotropin, and in the corticotrophs PC1 is the more abundant enzyme (Day et al., 1992) . However, in the intermediate lobe POMC is processed into cY-melanocyte stimulating hormone (LU-MSH), and in this tissue PC2 is much more abundant than PC1 (Seidah et al., 1990, 199 1; Benjannet et al., 199 1; Day et al., 1992) . From these biochemical studies it is concluded that PC1 and PC2 represent distinct prohormone convertases that produce distinct sets of tissue-specific maturation products in the anterior and intermediate pituitary lobes. The coregulation of convertase gene expression with POMC gene expression in the intermediate lobe (Birch et al., 199 1; Bloomquist et al., 199 1; Day et al., 1992) further suggests the importance of a coordinate action between enzyme and substrate. We now extend these studies to the CNS by examining in detail the expression of PC1 and PC2 using in situ hybridization.
Furthermore,
we compare this distribution to that of furin, whose cellular CNS localization
has not yet been described.
Finally, these distributions are compared to that of two known processing enzymes, CPE and PAM. Our comparative data suggest that both neuronal and non-neuronal elements in the CNS are capable of specific posttranslational processing patterns that are determined by the specific expression and abundance of each of the convertases. Finally, the present data may help to provide some further insight into the combination ofconvertases necessary to generate tissue-specific neuropeptide products and active proteins.
Materials and Methods
Tissue preparation. Brains from male Sprague-Dawley rats (200-250 gm) were rapidly removed and frozen in isopentane cooled to -30°C to -50°C on dry ice. Fifteen-micrometer-thick sections were cut on a cryostat (Hacker Instruments) in frontal, horizontal, or sag&al planes, thaw mounted on polylysine-coated slides, and stored at -70°C until further processing.
Probe synthesis. )S-labeled cRNA probes were generated for furin, PCl, PC2, CPE, and PAM from cDNA subclones in transcription vectors. Rat (r) PC1 and rPC2 cDNAs were obtained using PCR as previously described (Day et al., 1992) . The rPC1 probe [492 nucleotides (nt)] was completely sequenced and shown to have a 97% homology to me&e (m) PCl, corresponding to nt 7 15-l 206. The rPC2 probe (450 nt) was 95% identical to mPC2. corresnondina to nt 878-1326. The f&in probe corresponded to nt 69I-1935bfthe rat cDNA clone (Misumi et al., 1990) . Following synthesis, the furin cRNA probe was exposed to mild alkaline hydrolysis to decrease probe length to 300-400 nt as previously described (Seidah et al., 1992) . The CPE probe was complementary to nt 1080-1470 of the PCR-generated rat cDNA clone (Fricker et al., 1989) . The PAM probe corresponded to nt 164-l 197 of the rat cDNA clone (Eipper et al., 1987) and has previously been used in situ hybridization studies . Specific activities of the generated cRNA probes were as follows: furin, 600,000 Ci/mmol; PCl, 250,000 Ci/mmol; PC2,240,000 Ci/mmol; CPE, 95,000 Ci/mmol; PAM, 30,000 Ci/mmol.
In situ hybridization histochemistry. In situ hybridization histochemistry was performed according to a previously reported protocol . Briefly, frozen sections were fixed in 4% phosphate-buffered formaldehyde solution for 60 min at 4°C and then washed three times in 0.05 M PBS, pH 7.4, for 10 min each. Deproteination was carried out with proteinase K (1 pg/ml) for 10 min at 37°C. Slides were transferred to 0.1 M triethanolamine, pH 8.0, and incubated in the same solution containing acetic anhydride (0.25% v/v) for 10 min at room temperature (RT). Sections were then rinsed in 2 x saline-sodium citrate (SSC) and dehydrated in ethanol (50-100%). Radioactive cRNA probes were diluted in hybridization buffer [75% forrnamide, 10% dextran sulfate, 3 x SSC, 50 mM NaPO,, pH 7.4, 1 x Denhardt's (0.02% each of Ficoll400, polyvinylpyrrolidone, BSA), 0.1 mg/ml yeast RNA] to a final concentration of 34 x lo4 dpm/pl. Dithiothreitol was added to a final concentration of 10 mM. Hybridization mix (30-50 ~1 per slide) was applied and sections were coverslipped and sealed with rubber cement. The tissue was incubated in the hybridization oven at 55°C for 16 hr. The next day coverslips were removed in 2 x SSC. Sections were treated with RNase A (200 &ml) at 37°C for 60 min to remove single-stranded RNA molecules. Successive washes followed at RT in 2 x, 1 x , 0.5 x, and 0.2 x SSC for 10 min each and in 0.2 x SSC at 60°C for 1 hr. The tissue was then dehydrated and exposed to Kodak XAR x-ray film from 14 (CPE, 1 d; PCl, PC2, furin, and PAM, 4 d). For microscopic analysis, sections were dipped in Kodak NTB2 nuclear emulsion and stored at 4°C. Following exposure times from 1 to 8 weeks (CPE, 6 d, PC 1, PC2, furin, and PAM, 30 d), autoradiograms were developed in Kodak D19 at full strength for 2 min and fixed in Rapid Fix (Kodak) for 4 min. To identify cellular structures, some of the autoradiograms and some adjacent nonhybridized sections were counterstained with cresyl violet.
Controls. The same cRNA probes for furin, PC 1, and PC2 have been shown previously in Northern blot analysis to recognize the correct mRNA sizes (Day et al., 1992) . As negative in situ controls, tissues were either treated with RNase A (200 pg/ml at 37°C for 60 min) prior to hybridization or probed with the sense-strand probes of the same size and specific activity. Positive labeling was never encountered in these experiments.
Results
The probes of similar length and specific activity, the mRNA levels of these two enzymes were more comparable. PC2 showed a broader distribution in various brain regions, but with a preferential localization in neuronal tissue. PC 1 was more restricted in its distribution pattern, but was expressed in high levels in some regions, which will be described in more detail below. Compared to CPE mRNA, levels PC1 and PC2 mRNAs were in general a factor of 1 O-fold lower, and compared to PAM mRNA, l-or 2-fold lower. Furin mRNA exhibited the lowest expression levels of all enzymes studied. These estimates of relative abundance compare well with that observed with Northern blot analysis of various brain regions (data not shown). It should be noted that occasionally higher labeling was observed on one side of the brain sections (see Figs. 1, 2) but these differences could never be confirmed in adjacent sections, and are most likely due to variations in the in SUM hybridization method.
Anatomical distribution qffurin rnRNA The expression of furin mRNA in the rat CNS was ubiquitous. All brain areas exhibited low to moderate levels (Figs. 1, 2C, JJ,M. R). Following exposure times of 30 d, positive labeling could be detected both in neuronal and non-neuronal tissues as listed in Table 1 , and was not confined to known neuropeptiderich regions. Interestingly, some brain regions exhibited relatively high levels of furin mRNA. These included areas of the olfactory bulb ( Fig. 1 C) , the piriform cortex ( Fig. lH) , the hippocampal formation (Fig. 2C ), the cerebellar cortex (Fig. 2R ). Non-neuronal tissues with very high levels of furin mRNA included the ventricular ependyma of the lateral ventricle ( Fig.  IH ) and the central canal (see Fig. 12B ), the choroid plexus ( Fig. IM) , and the circumventricular organs, including the subfornical organ (Fig. IM) and the area postrema (Fig. 2R) . Surprisingly, the highest levels of furin mRNA were observed over the granular cells ofthe islands ofcalleja (Fig. 4&C ), which also expressed moderate levels of CPE (Fig. 4'1) . PC 1 and PC2 mRNA were not detectable in this tissue. Higher-magnification analyses suggested that the observed higher levels of furin mRNA in the brain regions described above are not simply due to a greater "packing density" of the cells in these areas, but rather that individual cells express relatively higher levels of furin mRNA.
Distribution sf PC1 and PC2 mRNA O!factorv system. In the olfactory bulb a moderate to dense labeling was observed for both PCI and PC2 mRNA in distinct layers ( Fig. 1 A,B) . PC2 mRNA was observed in many cell types at moderate levels including the tufted cells, the mitral cells, and the periglomerular and granular cells (Table I) . PC 1 mRNA was expressed at higher levels than PC2 mRNA only in the tufted cells and in the anterior olfactory nucleus. In the other cell layers PCI mRNA was present only at low levels of expression. Interestingly, while furin mRNA was present in all cell layers at moderate levels, it was very highly expressed in the tufted cells and the external plexiform layer (Fig. 1C ). All olfactory regions expressed CPE and PAM mRNA at moderate to high levels (Table 1) . Telencephalon Neocortex. In the cerebral neocortex, PC1 and PC2 mRNAs were heterogeneously distributed. PC1 was expressed in temporal cortex at moderate levels in layers 2-6, with higher expression levels in the deep layers and low to undetectable levels in portions of layers 4 and 5 (Fig. 1K ). PC2 mRNA, imitating the distribution pattern of PAM ( Fig. 1 T) , was highly expressed in layers 2-3 and 5-6, but very low to absent in layer 4 (Fig.  1Q ). In contrast, furin mRNA expression was highest in layer 4, with low levels of expression in all other cortical layers (Figs. lR, 2C).
Hippocampal formation. High levels of RNA transcripts encoding all enzymes were present in the hippocampal formation. While furin mRNA was expressed at very high levels in all hippocampal subregions (Fig. 2C ), PC1 and PC2 mRNAs showed distinct differences in distribution. In the pyramidal cells of the subfields CAl-CA4, PC2 mRNA was more abundant than PC1 (Fig. 3B ), whereas the reverse was observed in the granular cell layer of the dentate gyrus, which exhibited higher levels of PC1 mRNA (Fig. 3A) . The expression patterns of CPE and PAM mRNA were similar to that of PC2.
Amygdafa. Distinct distribution patterns for PC1 and PC2 were observed in the peptide-rich nuclei of the amygdaloid body. While all enzymes were present in the basolateral nucleus of amygdala at medium to high levels ( Fig. 2A-E ), PC2 mRNA was more abundant than PC1 in this region. In contrast, in the basomedial and medial nucleus and in the anterior cortical nucleus the relative levels were reversed. The central nucleus expressed the lowest levels of any enzyme mRNA.
Basal forebrain areas All enzyme mRNAs were present in the rostra1 forebrain including the septal nuclei, bed nucleus of stria terminalis, and diagonal band nuclei (Fig. 1, Table 1 ) with strong region-specific differences. For example, in the lateral septal nucleus, PC2 mRNA was expressed at high levels in the dorsal subdivision, furin and CPE mRNAs were also present, but neither PC1 nor PAM mRNA could be detected, suggesting the potential initial processing of precursors to nonamidated peptides by PC2 and/ or furin. In the anterior portion of the medial preoptic nucleus, PC1 mRNA was more abundant than PC2, while furin, CPE, and PAM were present at moderate to high levels. Similarly, in the bed nucleus of the stria terminalis, PC1 mRNA was expressed at higher levels than PC2. A striking distribution pattern was observed in the granule cells of the islands of Calleja (Fig.  4) , which are known to synthesize no identified neuropeptides, but which exhibited one of the highest levels of furin mRNA in the entire brain, as well as high levels of CPE mRNA. Transcripts coding for PC 1, PC2, and PAM were not detectable. The subfomical organ showed a striking high expression for all enzyme genes, in particular for furin and PC1 (Fig. lK,M) .
Basal ganglia. All the enzyme mRNAs were expressed throughout the basal ganglia. In the caudate-putamen, mRNAs coding for PC2 and CPE were expressed at moderate to high levels ( Fig. l) , while furin and PAM were expressed at lower levels. Regional expression of PC1 mRNA in caudate-putamen was low (Fig. 1) . However, upon closer inspection, a small percentage of striatal cells exhibited relatively high levels of PC1 mRNA (Fig. 5) . Counterstaining of these and adjacent sections revealed that PC1 mRNA was expressed over large neurons (Fig. 5A) , resembling the cholinergic neurons in size and distribution (Bolam et al., 1984; Heimer et al., 1985) . Numerous small and medium-size neurons throughout the caudate-putamen expressed moderate levels of PC2 mRNA (FigSB). These include most likely the medium spiny striatopallidal projection neurons, known to synthesize proenkephalin-derived opioid peptides. In the nucleus accumbens and ventral pallidurn, enzyme transcript levels were low to moderate with a higher expression of PC2 than PC1 mRNA (Fig. lF,G) , with the exception of the few scattered large-size neurons exhibiting high levels of PC1 mRNA. The globus pallidus exhibited only low levels of PC2 mRNA, and PC1 mRNA was close to detection limit ( Fig. 1 K,L) .
Choroid plexus. In the region of the rostra1 forebrain, high levels of furin and CPE mRNA were observed in non-neuronal tissue such as the choroid plexus (Fig. 6&E ). PAM mRNA, as previously described, was present in the ventricular ependymal cells together with furin and CPE , particularly concentrated in the region of the anterior horn of the lateral ventricle neighboring the caudate-putamen (Fig. 6fl . Neither PC1 or PC2 transcripts could be detected in these nonneuronal tissues, but they were prominent in neighboring structures including hippocampus, thalamus, and striatum.
Diencephalon
Thalamus. Throughout the thalamus, previously shown to be rich in processing enzyme content of CPE and PAM, high expression levels of PC2 mRNA were noted, with the exception of the reticular nucleus and the posterior thalamic group (Fig.  1) . The thalamic expression of PC1 mRNA was much more restricted. Relatively high levels were seen in the anterodorsal nucleus, here coinciding with high levels of PAM mRNA, and the paraventricular region. Low to undetectable levels observed in the ventral nuclei. In the reuniens nucleus, no PC1 mRNA could be detected, but a dense labeling for PC2 mRNA was observed (Fig. lP,Q) . PAM mRNA distribution was almost identical to that of PC2, with less labeling over the ventrolateral nucleus and the midline nuclei ( Fig. 1 Q, 7' ). The expression patterns of PC2 and PAM mRNA were reminiscent of that reported for the mRNA coding for the amidated peptides cholecystokinin and the chromogranins (Ingram et al., 1989; Mahata et al., 199 1) . Furin mRNA was expressed only at low levels (Fig. 1R) .
Habenula. The habenula, a region with known expression of amidated neuropeptides such as the tachykinins (Burgunder and Young, 1989) , exhibited high levels of PC1 and PC2 with distinct distribution patterns (Fig. 7) . While PC1 mRNA was more abundant in the lateral part of the medial habenula, the reverse was true for the expression of PC2 mRNA in the medial part. In the ventral portion of the lateral habenula, PC1 mRNA was more highly expressed than PC2, and high levels of expression of PAM transcripts were noted or previously reported . Hypothalamus. In the hypothalamus, the brain region with the highest concentration of neuropeptides, all processing enzyme transcripts were present with prominent region-specific differences. For example, the magnocellular neurons of the supraoptic nucleus (Fig. 8 ) and paraventricular nucleus (Fig. 9) well characterized in respect to their content of multiple neuropeptides, expressed significantly higher levels of PC1 mRNA than PC2 mRNA. Furin and CPE mRNA were also present in the magnocellular neurons. PAM mRNA showed the highest expression level in magnocellular neurons. The suprachiasmatic Figure S . Localization of PC1 mRNA (A) and PC2 mRNA (B) in the hippocampal formation. Note the differential expression in the various subregions. A, PC1 mRNA is present in granular layer of CAl-CA3, but was most abundant in the dentate gyrus (DC). B, In contrast, PC2 mRNA levels are the lowest in the dentate gyrus and the highest in CA2 and CA3 region. Exposure time, 30 d. Scale bar, 0.5 pm. nucleus and the medial preoptic nucleus were other areas with higher levels of PC 1 mRNA than PC2 mRNA. More PC2 mRNA than PC1 mRNA was found in the anterior hypothalamic area and in the parvocellular subdivisions of the paraventricular hypothalamic nucleus, particularly in the lateral and medial parvocellular neurons (Fig. 9B) , known for their synthesis of the amidated peptide corticotropiri-releasing hormone (CRF) (Antoni et al., 1983) . Here, PC 1 mRNA was also present, but mainly in the scattered magnocellular neurons present in this region. CPE mRNA was also expressed at high levels with slightly higher expression in the magnocellular region. The optic tract, adjacent to the supraoptic hypothalamic nucleus contained furin and CPE mRNA, most likely in glial elements (Vilijn et al., 1989) , such as astrocytes or oligodendrocytes (Fig. 840 . In the basal hypothalamus in the region of the arcuate nucleus, transcripts coding for both PC1 and PC2 were detected (Fig. 10) . While Following exposure times of 30 d, strong positive labeling for PC1 mRNA (A) could be detected over a small percentage of scattered cells in the caudate-putamen (CPU). Under bright-field examination the counterstained sections revealed that the scattered cells (arrows in a) resembled in size and distribution the cholinergic interneurons. Labeling of smaller-size neurons with the PC1 cRNA probe was weak and in most instances close to background levels (a). In contrast, PC2 mRNA levels were high throughout the caudate-putamen (B). Numerous small-to medium-size neurons were identified as the PCS-expressing neurons (arrows in b), which includes the proenkephalin-producing striatopallidal projection neurons. Scale bars: A and B, 0.5 mm; a and b, 50 pm. Figure 6 . Localization of processing enzymes in the region of the lateral ventricle. For identification of cellular structures adjacent section was counterstained with cresyl violet (A). The choroid plexus and the ependyma of the lateral ventricle (ep) were positively labeled when hybridized with probes coding for furin (B) and CPE (E). PAM mRNA (F) was present in the ependyma, particularly in the region bordering the caudateputamen. No positive signal in this non-neuronal structures was observed for PC1 mRNA (C) or PC2 mRNA (D), which showed moderate to high expression in the neighboring neuronal areas including the hippocampus, thalamus, and cortex. Scale bar, 0.5 pm.
PC2 mRNA appeared to be more abundant in the region where POMC-producing arcuate cells are localized (Fig. IOB) , PC1 was also present at lower levels, but was highly expressed in large neurons in the region ventral to the ventromedial nucleus. CPE and PAM mRNA were also present at moderate levels. The ventromedial nucleus exhibited higher levels of PC2 than PC1 mRNA. Striking regional differences were observed in the mammillary body. Here, PC1 mRNA was expressed at high levels in the supramammillary nucleus (Fig. 1lA) and the tuberomammillary nucleus, where only low to moderate expression of PC2 mRNA was seen. In contrast, in the medial mammillary nucleus PC1 mRNA levels were undetectable, but PC2 expression was relatively high (Fig. II@. In the lateral hypothalamic area, large cells containing high levels of PC2 mRNA were observed that appeared to correspond to the melanin-concentrating hormone (MCH)-containing neurons. Other large neurons labeled prominently for PC1 did not appear to correspond to MCH cells (Seidah et al., in press ).
Mesencephalon and rhombencephalon PC1 and PC2 mRNAs were detected in most regions of the mesencephalon (Table 1 ). In the substantia nigra, a neuropeptide-rich region functionally belonging to the basal ganglia, enzyme mRNA levels were high, particularly in the pars compacta (Fig. 1 1) , where all were expressed at moderate to high levels. In the pars reticulata PC2 mRNA (Fig. 1lB ) was more abundant in scattered cells than PC1 (Fig. 1lA) . A similar distribution pattern was observed in the ventral tegmental area.
Higher levels of PC2 mRNA than PC1 were observed in most areas including the central gray, rostra1 linear nucleus, red nucleus, and the intermediate gray layer of the superior colliculus. CPE and PAM were also present at high levels. In the medial geniculate nucleus (Fig. 2 ) PC 1 was absent or expressed only at low levels with the exception of the marginal zone, where PC1 was higher than PC2. All other subdivisions of the medial geniculate nucleus, including ventral, dorsal, and medial areas, contained relatively high levels PC2 mRNA, and the expression of PAM and CPE closely matched that of PC2 mRNA. The Edinger-Westphal nucleus expressed high PC 1 and PAM mRNA levels, but no PC2 mRNA. The rostra1 linear nucleus presented another example for intranuclear differences in expression of PC1 and PC2. In the lateral portion, high levels of PC2 mRNA were found and low expression of PCl, whereas in the medial portion PC1 mRNA was severalfold more abundant than PC2 mRNA.
In the pons and medulla, several nuclei expressed higher levels of PC1 mRNA than PC2. These include the median raphe nucleus, the dorsal part of the parabrachial nucleus, the Kolliker Fuse nucleus, the nucleus raphe pallidus, the dorsal cochlear nucleus, the medial vestibular nucleus, and the nucleus raphe magnus. High levels of PC2 mRNA, but only low to moderate levels of PC1 mRNA, were observed in the pontine nuclei, the locus coeruleus, ventral tegmental nucleus, and most motor nuclei of the cranial nerves including the trochlear nucleus, abducens nucleus, facial motor nucleus, and hypoglossal nucleus (Fig. 12) . In the nucleus of the solitary tract (NTS), high levels of both PC1 and PC2 were present, however, with a different regional distribution (Fig. 12) . Whereas PC1 was more abundant in the medial portion, PC2 mRNA was more highly concentrated in the lateral region. Furin mRNA was expressed at low to moderate levels in almost all brainstem nuclei. Higher levels Figure 7 . Differential localization of processing enzymes in the habenulae. A, PC1 mRNA was particularly abundant in the lateral portion of the medial habenula (MHb), whereas PC2 mRNA was prominent in both medial and lateral areas of the medial habenula (B). The distribution of PC2 overlapped with that of PAM mRNA (C) in the medial habenula. In the ventral regions of lateral habenula, scattered neurons exhibited strong labeling for PAM mRNA (C) and moderate PC1 mRNA levels (A) and lower levels of PC2 mRNA (B). Scale bar, 0.5 pm. were observed in the ependyma ofthe central canal and the area postrema (Fig. 12B) . The dorsal motor nucleus of vagus had a reverse ratio of PCl:PC2. The inferior olivary complex, known to produce the C-terminally amidated peptide CRF, had higher levels of PC2 mRNA as compared to PC1 .
Cerebellar cortex A layer-specific expression pattern was observed in the cerebellar cortex (Fig. 13) . The Purkinje cell layer expressed very high levels of furin, PC2, and CPE and moderate levels of PC1 . PC2 mRNA was also present over Golgi II cells scattered in the granular cell layer (Fig. 13B) , which are known to synthesize proenkephalin (Harlan et al., 1987) . In the granular layer low levels of furin and PC2, but not PCl, and moderate levels of CPE mRNA was present. No positive labeling for PC1 and PC2 mRNA occurred over the molecular layer (Fig. 13A,B) , whereas furin and CPE were expressed at low to moderate levels. No PAM mRNA could be detected in the cerebellar cortex, as previously reported .
Spinal cord All enzymes were expressed in the spinal cord, with higher levels in the superficial layers of the dorsal horn and the motor neurons of the anterior horn (see Table 1 ). PC2 mRNA was expressed at high levels in the superficial layers and in large neurons in the deep layers of the dorsal horn known for the production of opioid peptides, and at very high levels in the large motor neurons of the anterior horn (Fig. 14B ). In the ventral horn, PC1 mRNA was expressed at only moderate levels in the large cy-motor neurons (Fig. 14A ). In the superficial dorsal horn, PC1 mRNA-positive cells were small and more scattered, with a higher concentration in laminae 1 and 3, 4 and 5. No positive signal for either PC1 or PC2 was observed in the white matter of the spinal cord. This was in contrast to the distribution of furin and CPE mRNA, which could be observed over cellular elements in both white and gray matter. The distribution of PAM mRNA was strikingly similar to PC2, particularly in the dorsal horn (data not shown). Transcripts coding for either PC1 (A) or PC2 (B) were observed in the arcuate nucleus (Arc) and adjacent areas of the basal hypothalamus.
PC2 mRNA was more abundant in the arcuate nucleus proper along the third ventricle (3 V') where POMC neurons are located. PC 1 mRNA was more prominent in the adjacent area ventral to the ventromedial hypothalamic nucleus (VMH). All areas contained high levels of CPE mRNA (C) and PAM mRNA (D). Scale bar, 0.25 pm.
Discussion
The mRNAs coding for the prohormone processing enzymes furin, PCl, and PC2 were localized throughout the rat brain using in situ hybridization histochemistry. Although regional overlaps occurred, each enzyme exhibited a unique expression pattern. The distribution pattern for CPE and PAM mRNAs have previously been described (MacCumber et al., 1990; Schafer et al., 1992) , and our data generally matched that of the literature. The genes coding for the prohormone convertases PC 1 and PC2 are widely expressed often in the same areas, but usually with a distinct distribution pattern, at the subnuclear level. High levels of expression of PC1 and PC2 mRNA were observed in neuropeptide-rich regions such as the hypothalamus, hippocampus, and cerebral cortex. These areas are also characterized by the relatively high expression ofCPE and PAM. In general, PC1 mRNA distribution is more restricted, compared to PC2. An impressive example is the thalamus, where almost all the thalamic nuclei express PC2 mRNA, but PC1 mRNA is found at high levels only in the anterior subdivisions. These unique distribution patterns of PC1 and PC2 mRNAs and the observed differences in their relative ratios of expression at the cellular level suggest distinct roles in the activation of brain proproteins. This variation in cellular mRNA levels may have significance for region-specific posttranslational processing. In other words, the same substrate proneuropeptide may well result in different biologically active end products depending on the ratio of PC1 :PC2 expression. This notion has already been demonstrated to be valid in understanding the differential posttranslational processing of pituitary POMC, which occurs were also present at moderate to high levels. In the pars reticula& PC2 mRNA (B) was more abundant than PC1 mRNA (A). In the mammillary body, a striking heterogeneity of processing enzyme distribution was observed. PC1 mRNA (A) was present only in the supramammillary nucleus (SUM), where with CPE and PAM transcripts were also expressed. In contrast, PC2 mRNA was expressed at high levels in the medial mammillary nucleus (MM), and at moderate levels in the lateral mammillary nucleus. While CPE mRNA was present at moderate levels in all subregions of the mammiliary body (C), PAM mRNA distribution was quite heterogeneous, with the highest levels in the lateral part of the medial mammillary nucleus, and lowest levels in the lateral mammillary nucleus. Scale bar, 0.5 Mm.
in the anterior lobe corticotrophs and the intermediate lobe melanotrophs (Day et al., 1992; Benjannet et al., 1991) . In the corticotroph, POMC is processed mostly into ACTH and P-lipotropin, and these cells express higher levels of PC1 than regions (see Figs. 10, 12) . Precise colocalization studies will be needed in order to establish the exact relationship of POMC and PC1 or PC2 mRNAs in the arcuate and NTS neurons. Furthermore, similarities in distribution patterns of neuropeptides and convertases can point to potential precursor selectivity for each convertase. For example, the expression of cholecystokinin in the neocortex and the thalamus closely resembles the distribution pattern of PC2. Other possible precursor substrates for PC2 could be proenkephalin, which shows a similar distribution pattern in the caudate-putamen, and calcitonin generelated peptide, which is synthesized in the motor neurons of spinal cord, where PC2 is highly expressed. However, the situation in the brain is further complicated by the complex and multiple coexistence of several neuropeptides in the same neuron is the rule rather than the exception. For example, magnocellular hypothalamic neurons in the paraventricular and supraoptic hypothalamic nuclei produce almost all of the neuropeptides present in hypothalamus. Therefore, it can be Figure 12 . focalization of processing enzyme mRNAs in the caudal brainstem. For identification of cellular structures an adjacent section (A) was counterstained with cresyl violet. High levels of furin mRNA (B) were observed in the area postrema, where all other processing enzymes were also present, and in the ependymal cells of the central canal. PC1 mRNA (C) was abundant in the NTS and the dorsal motor nucleus of vagus, and to a lesser extent in the hypoglossal nucleus. Highest levels of PC2 mRNA (0) expression were seen in the ventrolateral region of the NTS and the hypoglossal nucleus. Expression in the dorsal motor nucleus of the vagus was weak in comparison to PC1 mRNA (c). CPE mRNA (E) was present in all regions. PAM mRNA Q was highly expressed in all regions mentioned above. Scale bar, 0.5 Wm. Figure 13 . Expression of prohormone convertases in the cerebellar cortex. A, Expression of PC1 mRNA is highly restricted to the Purkinje cell layer (XL). No labeling was observed over the molecular cell layer (ML). B, PC2 mRNA showed very high levels in the PCL and low levels in the granular cell layer (GCL), although some scattered cells in the GCL showed high expression levels. C, Furin mRNA was highly abundant in the PCL but also present at moderate levels in the GCL and ML. D, CPE mRNA showed high expression levels in all layers. PAM mRNA was undetectable as previously described. Scale bar, 0.5 pm.
misleading to pinpoint one specific neuropeptide precursor as study also suggest other functions of furin. The presence of furin substrate for a particular convertase even after their coexistence mRNA in non-neuronal cells such as the choroid plexus and has been demonstrated. Another level of complexity is added ependymal cells, cells lacking in dense core secretory granules, since the convertases may also be involved in functions other points to a possible role of furin as a convertase processing than processing proneuropeptides such as the activation of other proproteins in the constitutive secretory pathway. In the epenenzymes involved in cellular biosynthetic activity. For example, dymal cells of the lateral ventricle, where PAM is also expressed, the protein precursor for PAM contains pairs of basic amino furin is most likely the convertase responsible for the initial acids that require cleavage in order to release the various activcleavage step for the generation of a yet unidentified peptide( ities related to amidation (Eipper et al., 1987) . Interestingly, which may be amidated. Furthermore, in vitro studies have whenever CPE or PAM were highly expressed in a region, at shown that furin may be involved in the processing of a variety least one of the three endoproteases was also highly expressed.
of blood coagulation factors and growth factors (Bresnahan et The convertases themselves need to be cleaved to acquire acal., 1990; Wise et al., 1990; Misumi et al., 199 1) . The localizativity. Besides autoactivation of PC1 and PC2, it has been hytion of furin mRNA in the cellular elements lacking the bloodpothesized that another enzyme such as furin may be responsible brain barrier such as the circumventricular organs and the venfor activation. The ubiquitous distribution pattern of furin may tricular ependyma is certainly consistent with these results. In support this hypothesis. However, the findings of the present fact, the precursor of complement C3, which has recently been shown to be processed by furin (Misumi et al., 1991) , is expressed by cells that are located in these regions of high furin expression (M.K.-H. Schafer, unpublished observation). The high abundance of furin mRNA in the islands of Calleja, whose function is still unresolved, suggests that it is a region of high posttranslational processing activity.
The identification of specific combinations of processing enzymes in different brain regions suggests that specific enzymatic pathways are involved in precursor processing. For example, in the choroid plexus or in ependyma of the lateral ventricle, amidated peptides are likely generated by using furin as the precursor cleaving enzyme, since PC1 and PC2 are lacking. In the Edinger-Westphal nucleus, production of amidated peptides may be achieved by prior cleavage of the precursor by PC 1, since no PC2 is expressed. Whether these specific combinations of processing enzymes are responsible for region-specific differences in posttranslational processing awaits further study. While the expression of at least one of the three subtilisin-like mammalian proteinases has been demonstrated together with CPE and PAM in all brain regions studied, it is more than likely that given the The Journal of Neuroscience, March 1993 , 13(3) 1277 richness and complexity of the nervous system, other members of this family may yet be discovered in the CNS. 
